Normal epithelial cells trigger EphA2-dependent RasV12 cell repulsion at the single cell level by Hill, William & Hogan, Catherine
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/100164/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Hill, William and Hogan, Catherine 2017. Normal epithelial cells trigger EphA2-dependent RasV12




Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
  
Normal epithelial cells trigger EphA2-dependent RasV12 cell repulsion at the single cell level. 
 
William Hill1 & Catherine Hogan1* 
1 European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn 
Ellis Building, Maindy Road, Cardiff CF24 4HQ, UK.  
* Corresponding author  
 
Abstract 
Epithelial cells expressing oncogenic Ras (RasV12) are detected by normal neighbours and are 
often extruded from tissues. We recently demonstrated that differential EphA2 signalling drives the 
segregation of mutant cells from normal monolayers via cell repulsion and increased RasV12 cell 
contractility. EphA2 signalling on RasV12 cells is triggered by ephrin-A ligands presented by 
normal cells. Here, we show that normal epithelial cells trigger the repulsion and enhanced 
contractility of Ras-transformed epithelial cells at the single cell level. We also reveal that ephrin-A 
ligands expressed on RasV12 cells are not required to drive RasV12 cell segregation following 
interaction with normal cells. Thus, normal-RasV12 cell-cell interaction triggers EphA2 forward 
signalling in RasV12 cells to drive repulsion and segregation of the transformed cells.  
 
Introduction 
In epithelial tissues, transformed and normal cells compete for space and survival. This competitive 
process relies on the ability of a cell to detect changes in its neighbour, and results in the 
elimination of one cell population (1). Unsurprisingly, cell competition plays a role in quality 
control and homeostasis, and may also be tumour promoting or suppressive depending on the 
context and the genetic mutation expressed by the transformed cell (2). We have previously shown 
that epithelial cells expressing oncogenes such as RasV12 or v-Src are detected by normal 
neighbours and are eliminated by a process of extrusion (3, 4). Oncogene-expressing cells are 
predominantly extruded apically, suggesting that this process may be a protective mechanism 
against tumour initiation (5). Several studies have detailed the mechanisms underlying RasV12 cell 
extrusion. This process requires E-cadherin-dependent cell-cell adhesion between RasV12 and 
normal cells, signalling to the actin-myosin cytoskeleton (3, 4, 6), as well as to intermediate 
filaments in normal cells (7, 8). Moreover, downstream signals via Rho GTPases (9) and Rab5-
mediated endocytosis are also positive regulators of RasV12 cell extrusion (10). However, the 
upstream signal that triggers these events has remained elusive. We have recently revealed that 
epithelial cells detect and respond to neighbouring cells overexpressing Eph receptors (11). As a 
result, the Eph overexpressing cell is triggered to segregate and extrude from normal tissues both in 
  
vitro and in vivo. EphA2 receptor tyrosine kinase is a transcriptional target of Ras-MAPK 
signalling (12) and is expressed at elevated levels in epithelial cells expressing oncogenic RasV12 
in a MEK-ERK-dependent manner (11). Our data demonstrates that enhanced expression of EphA2 
in RasV12 cells promotes their detection by and separation from normal neighbours (11). Cell-cell 
interactions between normal and RasV12 cells induce EphA2 forward signalling on RasV12 cells in 
an ephrin-A ligand-dependent and E-cadherin-dependent manner. This triggers repulsion and an 
increase in cell contractility of RasV12 cells in direct contact with normal cells. In turn, 
neighbouring RasV12 cells that are positioned behind marginal cells and not in direct contact with 
normal cells are triggered to contract in an EphA2-dependent manner. In this study, we further 
explore RasV12-normal cell-cell interactions to show that RasV12 cell repulsion and segregation 
from normal cells occurs at the single cell level, independent of ephrin-A ligands expressed on 
RasV12 cells.  
 
Results and Discussion 
In order to explore cell-cell interactions between Ras-transformed and normal epithelial cells, we 
use co-culture systems and Madin-Darby canine kidney (MDCK) epithelial cell lines, expressing 
GFP-tagged, constitutively active, oncogenic Ras (RasV12) in a tetracycline/doxycycline-inducible 
manner (3, 11). Using these lines we generate mosaic epithelial cell sheets by mixing RasV12 cells 
with normal cells at 1:100 ratios in the absence of tetracycline (3, 11). Once cell-cell adhesion is 
established and an epithelial monolayer has formed, tetracycline is added to the cells and GFP-
RasV12 expression is induced. More recently, we have developed the cell confrontation assay, 
which allows collision between sheets of RasV12-expressing and normal cells (11). Using both 
assays we have demonstrated that interaction with normal cells triggers RasV12 cells to become 
round and contractile, and to segregate away from the normal cells. When present as single cells or 
small clusters within normal monolayers, RasV12 cells are eventually apically extruded from the 
tissue. In cell confrontation assays, collision with normal cells triggers a rapid cell repulsion of 
RasV12 cells; cells stop migrating forward and actively migrate backwards (11). In addition, 
normal cell sheets continued to migrate forward with intermingling between the two populations of 
cells significantly inhibited. We have previously shown that segregation of RasV12 cells from 
normal cells is driven by an EphA2-dependent cell repulsion (11). Moreover, neighbouring RasV12 
cells positioned behind the marginal cells that are not in direct contact with the normal cells also 
contract and round up in an EphA2-dependent manner (11). However, we could not conclusively 
determine whether this was a ligand-dependent process. Moreover, when using the confrontation 
assay, we were also unable to conclusively determine whether normal cell sheets, which migrate 
forward, were physically compressing the RasV12 cells backwards.  
  
To explore each of these points further, we used our MDCK cell systems to investigate whether 
normal cells could induce RasV12 cell repulsion and changes in RasV12 cell contractility when co-
cultured with RasV12 cells at low densities. In order to monitor cell repulsion, we first seeded GFP-
RasV12 cells as confluent monolayers in the presence of tetracycline, before adding normal cells 
(pre-labelled with cell tracker dye) to the apical side of the monolayers at low densities. In parallel, 
we added labelled GFP-RasV12 cells at low densities to the apical side of confluent normal 
monolayers, or to confluent monolayers of GFP-RasV12 cells. Cells were fixed 24 h later and 
monitored by immunofluorescence. We found that labelled normal cells flattened and spread with a 
regular morphology in between GFP-RasV12 cells (Figure 1). RasV12 cells juxtaposed to the 
normal cell cluster appeared round and contractile, and F-actin accumulated at cell-cell contacts 
between the contractile RasV12 cells (Figure 1). RasV12 cell repulsion was evident at the interface 
with the cluster of normal cells, as GFP-RasV12 cell membranes appeared smooth and free of 
protrusions, and cells often aligned perpendicular to the normal cell cluster (Figure 1, arrowheads). 
Labelled GFP-RasV12 cells dropped on top of GFP-RasV12 cells flattened, spread and formed 
homogenous cell-cell adhesions with unlabelled neighbours (Figure 1). In contrast, GFP-RasV12 
cells dropped onto confluent monolayers of normal cells did not spread or intercalate with the 
normal cells, but remained on top of the normal cells as tight clusters of contractile cells (Figure 1), 
similar to previous reports (3). Together, these data suggest that even when present at low numbers, 
normal cells can induce RasV12 cell repulsion and increased RasV12 cell contractility.  
We next tested the functional role of EphA2 in this assay, and used GFP-RasV12 cell lines that 
constitutively expressed EphA2 shRNA as previously described (11). When labelled normal cells 
were dropped on to monolayers of RasV12 depleted of EphA2, we did not observe an increase in 
RasV12 cell repulsion and contractility (Figure 2). Here, RasV12 cells appeared regular in shape 
and formed homogenous cell-cell adhesions with the normal cells. Moreover, when dropped onto 
normal monolayers, RasV12 cells depleted of EphA2 spread and formed cell-cell adhesions with 
normal cells (Figure 2). We observed that labelled RasV12 cells added to monolayers of RasV12 
cells depleted of EphA2 remained as contractile clusters of cells, on the apical side of the 
monolayer (Figure 2). This was not surprising since RasV12 cells constitutively expressing EphA2 
shRNA behave like normal cells in coculture assays (11). Together these data support our previous 
findings that EphA2 expressed on RasV12 is required to drive RasV12 cell repulsion and 
contraction following interaction with normal cells.  
In our previous study, we demonstrated that removal of ephrin-A-ligands from the cell surface of 
non-transformed cells, or depletion of EphA2 expressed on RasV12 cells promoted intermingling of 
RasV12 cells with non-transformed cells, the loss of RasV12 cell contractility, and the formation of 
basal protrusions. Moreover, preclustered ephrin-A ligands triggered cell repulsion, or clustering of 
  
RasV12 cells in the absence of non-transformed cells. Thus, our data suggested that forward 
signalling via EphA2 receptor expressed on RasV12 cells is sufficient to induce contractility and 
clustering of RasV12 cells following interaction with non-transformed cells. RasV12 cells express 
ephrin-A1 and -A4 mRNA at levels equivalent to normal cells (11). Therefore, we wanted to 
explore whether ephrin-A ligands expressed on RasV12 cells are also required to drive RasV12 cell 
contractility and segregation. We reasoned that by using this new assay (as described above) we 
could explore the propagation of an Eph-ephrin signal between neighbouring RasV12 cells at the 
single cell level. We first removed GPI-linked ephrin-A ligands from the cell surface of RasV12 
cells by treating the cells with the enzyme phosphatidylinositol-specific phospholipase C (PI-PLC) 
in order to remove endogenous ephrin-A1 from RasV12 cells (11). We seeded PI-PLC treated (or 
PBS-treated) GFP-RasV12 cells as confluent monolayers before adding pre-labelled normal cells on 
top of the monolayers at low density. Cells were fixed and stained 24 h later. We found that normal 
cells flattened and spread into monolayers of both PI-PLC treated and PBS treated RasV12 cells 
(Figure 3). However, we found that RasV12 cell responses were dependent on the levels of EphA2 
expressed on RasV12 cells, irrespective of treatment. When the level of EphA2 expressed on 
RasV12 cells was high, we observed cell repulsion in both PBS and PI-PLC treated RasV12 cells in 
direct contact with normal cells. Moreover, RasV12 cells appeared round and contractile in both 
PBS and PI-PLC treated monolayers. Using phospho-specific antibodies to monitor Eph receptor 
clustering and activation (13), we detected elevated levels of phosphorylated EphA2 (Y594) in 
RasV12 cells expressing high levels of EphA2 and surrounding a normal cell cluster (Figure 3). In 
contrast, RasV12 cells expressing low levels of EphA2 showed low levels of cell repulsion and 
were not contractile following interaction with normal cells. Here, we detected low levels of 
phosphorylated EphA2. Together, these data suggest that ephrin-A ligands expressed on RasV12 
cells are not required to induce contractility and repulsion between neighbouring RasV12 cells 
following interaction with normal cells. These data also support our previous findings that 
differential EphA2 expression and hence signalling drives repulsion and segregation of cells 
expressing elevated levels of EphA2 receptor.  
In summary, we have shown that normal epithelial cells trigger the repulsion and enhanced 
contractility of Ras-transformed epithelial cells at the single cell level. Using a new coculture assay, 
we have demonstrated that even small clusters of normal cells can induce these responses in 
confluent monolayers of RasV12 cells. Thus, normal-RasV12 cell-cell interaction triggers a 
signalling event rather than normal cells compress RasV12 cells. We also found that ephrin-A 
ligands expressed on RasV12 cells do not play a role in RasV12 cell repulsion and contractility 
following interaction with normal cells. In our previous report we showed that RasV12 cells 
positioned behind the marginal cells and not in direct contact with normal cells are also triggered to 
  
contract in an EphA2-dependent manner (11). Our data presented here suggest that signalling from 
marginal RasV12 cells to neighbouring RasV12 cells, occurs in an ephrin-A ligand-independent 
manner. It is possible that EphA2 when present at elevated levels on RasV12 cell membranes 
becomes mobile and forms higher order clusters, promoting autophosphorylation events (14, 15). 
Activation of EphA2 in RasV12 cells drives RasV12 cell repulsion and changes in cell contractility 
in a myosin-II-dependent manner (11). Together with our previous findings, we conclude that cells 
detect and respond to steep differences in EphA2 expressed on neighbouring cells and it is this 
differential EphA2 signal that drives the repulsion and segregation of the EphA2 over expressing 
cell.  
 
Materials and methods 
Antibodies and Reagents 
Primary antibodies used: mouse anti-EphA2 (clone D7) (Millipore); rabbit anti-phospho-EphA2 
(Y594) (p-EphA2); mouse anti-GAPDH (Chemicon International); rabbit anti-ephrin-A1 
(SantaCruz); mouse anti-GFP (Roche). Secondary antibodies (Alexa-405- and Alexa-647-
conjugated anti-mouse and anti-rabbit) were from Life Technologies. Orange cell tracker dye 
(CMDRA) and phosphoinositide phospholipase C (PI-PLC) were both from Life Technologies.  
!
Cell culture and coculture assay 
Non-transformed MDCK cells, MDCK-pTR cell lines stably expressing GFP-RasV12 in a Tet-ON 
inducible manner or MDCK-pTR GFP-RasV12 expressing EphA2 shRNA were cultured as 
previously described (3, 11). MDCK-pTR-GFP-RasV12, non-transformed MDCK or MDCK-pTR-
GFP-RasV12 EphA2 shRNA cells were trypsinised and seeded on serum-coated 18mm
2
 glass 
coverslips, at a density of 1 x 10
6 
cells. Cells were incubated for 8-16 h at 37
o
C to allow the 
formation of a confluent monolayer. MDCK-pTR-GFP-RasV12 cell lines were cultured in the 
presence of tetracycline/doxycycline in order to induce GFP-RasV12 expression. The next day, 
non-transformed (normal) MDCK, or MDCK-pTR GFP-RasV12 cell lines pre-labelled with cell 
tracker dye (CMDRA) were dropped onto the monolayers at a density of 2 x 10
3
.  Cells were 
incubated for a further 24 h before fixation.  
Immunofluorescence 
Immunofluorescence of cells cultured on serum-coated glass coverslips was performed as 
previously described (3, 11). Anti-EphA2 antibody was used at a dilution of 1:100; anti-
phosphorylated-EphA2 antibody was used at 1:50. All secondary antibodies were used at 1:200. 
TRITC-phalloidin (Sigma-Aldrich) was used at 1.5 µg ml
-1
. Cells cultured on glass coverslips were 
  
examined using a Zeiss LSM710 confocal microscope. Images were analysed using Zen (Zeiss 
Efficient Navigation) software, or Fiji (National Institute of Health) (v1.48j) software. 
!
PI-PLC treatment 
Endogenous ephrin-A ligands were cleaved from the cell surface of non-transformed cells as 
previously described (11, 16). Briefly, cells were pre-treated with 1 U ml
-1
 PI-PLC or an equivalent 
volume of PBS for 4 h before being switched back to regular DMEM/FCS media. Cells were then 
trypsinised and seeded on serum-coated coverslips at a density of 1 x 10
6
. Cell lysates were also 
harvested in RIPA buffer at 4 h or 28 h post-treatment. Immunoblotting analyses were performed 
using the following antibodies: mouse anti-GAPDH at 1:2,000, rabbit anti-ephrin-A1 at 1:500. 
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Figure 1. Normal cells induce RasV12 cell repulsion and increased contractility at the single 
cell level. 
Confocal images of coculture assays. Upper panels: Normal MDCK cells prelabelled with cell 
tracker dye (CMDRA) are added to confluent monolayers of GFP-RasV12 cells. Middle panels: 
GFP-RasV12 cells prelabelled with cell tracker dye (CMDRA) are added to confluent monolayers 
of GFP-RasV12 cells. Lower panels: GFP-RasV12 cells prelabelled with cell tracker dye 
(CMDRA) are added to confluent monolayers of normal MDCK cells. Cells were fixed 24 h after 
addition of prelabelled cells and stained with phalloidin (gray) and Hoechst (blue). Scale bar, 20 
µm. 
 
Figure 2. EphA2 receptor expressed on RasV12 cells is required to drive RasV12 cell 
repulsion and contractility following interaction with normal cells.  
Confocal images of coculture assays. Upper panels: Normal MDCK cells prelabelled with cell 
tracker dye (CMDRA) are added to confluent monolayers of GFP-RasV12 cells constitutively 
expressing EphA2 shRNA. Middle panels: GFP-RasV12 cells prelabelled with cell tracker dye 
(CMDRA) are added to confluent monolayers of GFP-RasV12 cells constitutively expressing 
EphA2 shRNA. Lower panels: GFP-RasV12 cells constitutively expressing EphA2 shRNA 
prelabelled with cell tracker dye (CMDRA) are added to confluent monolayers of normal MDCK 
cells. Cells were fixed 24 h after addition of prelabelled cells and stained with phalloidin (gray), 
anti-EphA2 antibody (magenta) and Hoechst (blue). XY images represent maximum projections of 
z-stacks. Scale bar, 20 µm. 
 
 
Figure 3. RasV12 cell repulsion and contractility is dependent on endogenous EphA2 
expression levels and not on coexpressed ephrin-A ligands.  
Confocal images of coculture assays. (A) Normal MDCK cells prelabelled with cell tracker dye 
(CMDRA) are added to confluent monolayers of GFP-RasV12 cells that expressed high levels of 
EphA2 and were pretreated with either PBS (upper panels) or phosphoinositide phospholipase C 
(PI-PLC) (lower panels). (B) Normal MDCK cells prelabelled with cell tracker dye (CMDRA) are 
added to confluent monolayers of GFP-RasV12 cells that expressed low levels of EphA2 and were 
pretreated with either PBS (upper panels) or phosphoinositide phospholipase C (PI-PLC) (lower 
panels). Cells were fixed 24 h after addition of prelabelled cells and stained with anti-EphA2 
  
(magenta), anti-phosphorylated EphA2 (Y594) (phospho-EphA2; cyan) and Hoechst (blue). XY 
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